Amerant Q3 EPS Jumps to $0.65; Board Lifts Buyback to $50M and Keeps $0.09 Dividend
AMTB sits 90% above its 52-week low of $15.62.
Summary
Amerant earned $0.65 per diluted share in Q3 2026, up from $0.53, on stronger net interest income and lower problem loans. The board also increased its buyback authorization to $50 million and extended it through 2027 while keeping the $0.09 dividend.
Key Events · Earnings and Guidance · AMTB
-
Q3 EPS Rises to $0.65
Net income attributable to Amerant was $25.7 million, or $0.65 per diluted share, versus $21.0 million and $0.53 in Q2 2026.
-
Net Interest Income Up 9.6%
Net interest income rose to $90.5 million from $82.6 million and NIM widened to 3.77% from 3.52%, helped by $1.6 million of interest from nonaccrual loan repayments.
-
Buyback Raised to $50 Million
The board extended the repurchase program to December 31, 2027 and increased available capacity to $50 million from approximately $3 million.
-
Dividend Held at $0.09
A $0.09 per share cash dividend is payable November 27, 2026 to shareholders of record on November 13, 2026.
Analysis · AMTB · Finance
Third-quarter net income rose to $25.7 million, or $0.65 per diluted share, from $21.0 million and $0.53 in the second quarter, as net interest income climbed 9.6% to $90.5 million and the net interest margin widened to 3.77% from 3.52%. Credit kept improving: non-performing assets fell 14.5% to $159.5 million and classified loans dropped 22.0% to $213.0 million. For holders, the bigger news is capital return — the board extended the repurchase program a year to December 31, 2027 and raised available capacity to $50 million from roughly $3 million, alongside an unchanged $0.09 quarterly dividend. Management guided fourth-quarter NIM down to 3.65%-3.70% and set a roughly 60% efficiency ratio target, so the margin expansion is not assumed to repeat.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 29.3% of the 1526 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMTB was trading at $29.66 on NYSE in the Finance sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $15.62 to $30.60. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.